The combination will now join Bristol Myers Squibb’s Opdivo in the list of bladder cancer drugs available on the NHS.

A new treatment regimen for advanced bladder cancer combining MSD's Keytruda with Astellas' Padcev has been given the green ...

While this new treatment offers a vital lifeline, experts are simultaneously stressing the critical importance of recognising ...

Pfizer Inc. and Astellas Pharma Inc. have announced positive topline results from the Phase 3 EV-303 clinical trial (also ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Friday, August 22, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.

"Prior to the EV-302 clinical trial, the treatment of advanced bladder cancer treatment hadn't significantly changed since ...

Pfizer's oncology portfolio, boosted by Seagen and strong drug sales, fuels Q2 growth and positions the company for future ...

Excitement is building as a new treatment for advanced bladder cancer that doubles survival time has been approved for NHS ...

The NHS will roll out a new treatment for advanced bladder cancer which doubles survival time. It's estimated that 1,250 ...

Experts said the approval of the new treatment combination would bring a ‘fundamental shift’ in care for patients with ...